Learn how our teams utilize real-world research to understand the lived impacts of sickle cell disease and beta thalassemia.

Cells are often called the building blocks of life, and cell therapies are one of the ways we’re trying to unlock innovative ways to treat serious diseases.

On World Blood Donor Day, hear from two individuals living with sickle cell disease and transfusion-dependent beta thalassemia as they share their stories, shed light on their struggles, and emphasize the impact blood donation has had on their disease and quality of life.

Paul Negulescu, Senior Vice President, Research, talks about the journey his team has taken over the last 20 years.

Learn about how small molecules can potentially make a big impact on the future of medicine. They are just one of our tools that are being investigated to unlock new ways to impact serious diseases.

Step inside our Boston Learning Lab and learn about our high school summer internship, one of our signature STEAM education programs.

Listen to Fred Van Goor, Vice President of Cystic Fibrosis Research, talk about our commitment to pursuing new therapeutic advances for all people living with cystic fibrosis and how this commitment drives scientific innovation.

Rebecca Hunt, Vice President of Patient and Community Engagement, highlights Vertex’s uncompromising commitment to patients.

Learn about an essential component in stem cell transplants, known as conditioning regimens. This is just one of the tools in our drug discovery toolbox that could support potential treatments.

Learn how Vertex remains committed to increasing representation in science and medicine through our partnership with the Biomedical Science Careers Program.